Single-arm, open-label, phase II study of LY3023414 for the treatment of recurrent or persistent endometrial cancer Meeting Abstract


Authors: Rubinstein, M. M.; Hyman, D.; Caird, I.; O'Cearbhaill, R.; Grisham, R.; Tew, W.; Hensley, M.; Sabbatini, P.; Aghajanian, C.; Iasonos, A.; Won, H.; Selcuklu, D.; Zimel, C.; Makker, V.
Abstract Title: Single-arm, open-label, phase II study of LY3023414 for the treatment of recurrent or persistent endometrial cancer
Meeting Title: AACR Special Conference on Targeting PI3K/mTOR Signaling
Journal Title: Molecular Cancer Research
Volume: 18
Issue: 10 Suppl.
Meeting Dates: 2018 Nov 30-Dec 3
Meeting Location: Boston, MA
ISSN: 1541-7786
Publisher: American Association for Cancer Research  
Date Published: 2020-10-01
Start Page: 50
Language: English
ACCESSION: WOS:000576804500075
PROVIDER: wos
DOI: 10.1158/1557-3125.PI3K-mTOR18-B18
Notes: Meeting Abstract: B18 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Vicky Makker
    267 Makker
  2. Paul J Sabbatini
    262 Sabbatini
  3. Alexia Elia Iasonos
    364 Iasonos
  4. Rachel Nicole Grisham
    171 Grisham
  5. Martee L Hensley
    290 Hensley
  6. David Hyman
    354 Hyman
  7. William P Tew
    247 Tew
  8. Helen Hyeong-Eun Won
    109 Won
  9. Catherine Zimel
    6 Zimel
  10. Imogen Caird
    5 Caird